Najjar, Devora http://orcid.org/0000-0001-9048-3592
Rainbow, Joshua
Sharma Timilsina, Sanjay http://orcid.org/0000-0001-7550-2724
Jolly, Pawan http://orcid.org/0000-0003-4076-2328
de Puig, Helena
Yafia, Mohamed
Durr, Nolan
Sallum, Hani http://orcid.org/0000-0002-0730-2859
Alter, Galit http://orcid.org/0000-0002-7680-9215
Li, Jonathan Z. http://orcid.org/0000-0001-9914-9662
Yu, Xu G.
Walt, David R. http://orcid.org/0000-0002-5524-7348
Paradiso, Joseph A.
Estrela, Pedro http://orcid.org/0000-0001-6956-1146
Collins, James J. http://orcid.org/0000-0002-5560-8246
Ingber, Donald E. http://orcid.org/0000-0002-4319-6520
Article History
Received: 17 August 2021
Accepted: 1 July 2022
First Online: 8 August 2022
Competing interests
: H.d.P., P.J., J.J.C. and D.E.I. are inventors on patents describing the CRISPR-EC sensing technology. P.J. and D.E.I. are listed as inventors on patents describing the EC sensor platform. The EC sensor platform technology has been licensed to Antisoma Therapeutics Inc. for infectious disease and cancer diagnostics and to StataDX Inc. for cardiovascular, neurological and kidney disease diagnostics. P.J. and D.E.I. hold equity in StataDx and D.E.I. is a board member. J.J.C. and D.R.W. are co-founders and directors of Sherlock Biosciences. The other authors declare no competing interests.
Free to read: This content has been made available to all.